Abstract
Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have